The latest closing stock price for Apellis Pharmaceuticals as of December 02, 2024 is 35.42.
An investor who bought $1,000 worth of Apellis Pharmaceuticals stock at the IPO in 2017 would have $1,525 today, roughly 2 times their original investment - a 14.14% compound annual growth rate over 7 years.
The all-time high Apellis Pharmaceuticals stock closing price was 93.31 on June 13, 2023.
The Apellis Pharmaceuticals 52-week high stock price is 73.80, which is 108.4% above the current share price.
The Apellis Pharmaceuticals 52-week low stock price is 24.34, which is 31.3% below the current share price.
The average Apellis Pharmaceuticals stock price for the last 52 weeks is 45.67.
An investor who bought $1,000 worth of Apellis Pharmaceuticals stock at the IPO in 2017 would have $1,525 today, roughly 2 times their original investment - a 14.14% compound annual growth rate over 7 years.
The all-time high Apellis Pharmaceuticals stock closing price was 93.31 on June 13, 2023.
The Apellis Pharmaceuticals 52-week high stock price is 73.80, which is 108.4% above the current share price.
The Apellis Pharmaceuticals 52-week low stock price is 24.34, which is 31.3% below the current share price.
The average Apellis Pharmaceuticals stock price for the last 52 weeks is 45.67.